P1204: AXICABTAGENE CILOLEUCEL VEIN-TO-VEIN TIME IN TRIAL OR REAL-WORLD SETTINGS VS OTHER CAR T-CELL THERAPIES FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Frederick Locke,
Michael T. Hemmer,
Steve Kanters,
Michael J. Zoratti,
Zhen-Huan Hu,
Harry Miao,
Shilpa Shahani,
Clare Spooner,
Christine Fu,
Anik Patel,
Hairong Xu,
Marcelo Pasquini
Affiliations
Frederick Locke
1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, United States
Michael T. Hemmer
2 Kite, a Gilead Company, Santa Monica, United States
Steve Kanters
3 RainCity Analytics, Vancouver, Canada
Michael J. Zoratti
3 RainCity Analytics, Vancouver, Canada
Zhen-Huan Hu
2 Kite, a Gilead Company, Santa Monica, United States
Harry Miao
2 Kite, a Gilead Company, Santa Monica, United States
Shilpa Shahani
2 Kite, a Gilead Company, Santa Monica, United States
Clare Spooner
2 Kite, a Gilead Company, Santa Monica, United States
Christine Fu
2 Kite, a Gilead Company, Santa Monica, United States
Anik Patel
2 Kite, a Gilead Company, Santa Monica, United States
Hairong Xu
2 Kite, a Gilead Company, Santa Monica, United States
Marcelo Pasquini
4 Center for International Blood and Marrow Transplant Research, Milwaukee, United States
